Oncotelic Therapeutics, Inc.
OTLC
$0.09
$0.000.54%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 409.00K | 88.00K | 79.20K | 86.10K | 149.00K |
| Total Receivables | 4.00K | 19.00K | 19.00K | 19.00K | 19.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.18M | 10.60K | 6.80K | 9.10K | 51.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.00K | 20.00K | 20.00K | 20.00K | 20.00K |
| Total Current Assets | 1.61M | 137.60K | 125.00K | 134.20K | 239.00K |
|
|
|||||
| Total Current Assets | 1.61M | 137.60K | 125.00K | 134.20K | 239.00K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.10M | 1.10M | 1.10M | 1.10M | 1.10M |
| Total Assets | 28.16M | 26.68M | 26.67M | 26.68M | 26.78M |
|
|
|||||
| Total Accounts Payable | 1.69M | 1.71M | 2.03M | 1.69M | 1.69M |
| Total Accrued Expenses | 1.22M | 1.13M | 776.30K | 1.09M | 1.12M |
| Short-term Debt | 13.87M | 13.55M | 13.29M | 13.09M | 10.64M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 3.30M | 2.90M | 3.39M | 3.33M | 2.91M |
| Total Other Current Liabilities | 3.30M | 2.90M | 3.39M | 3.33M | 2.91M |
| Total Current Liabilities | 20.08M | 19.29M | 19.48M | 19.20M | 16.36M |
|
|
|||||
| Total Current Liabilities | 20.08M | 19.29M | 19.48M | 19.20M | 16.36M |
| Long-Term Debt | -- | -- | -- | -- | 2.29M |
| Short-term Debt | 13.87M | 13.55M | 13.29M | 13.09M | 10.64M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 20.08M | 19.29M | 19.48M | 19.20M | 18.65M |
|
|
|||||
| Common Stock & APIC | 48.16M | 46.36M | 46.36M | 46.29M | 46.29M |
| Retained Earnings | -39.11M | -38.06M | -38.34M | -38.04M | -37.44M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.05M | 8.30M | 8.02M | 8.25M | 8.85M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.05M | 8.30M | 8.02M | 8.25M | 8.85M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -974.10K | -907.10K | -839.70K | -774.10K | -720.60K |
| Total Equity | 8.08M | 7.39M | 7.18M | 7.48M | 8.13M |
|
|
|||||